De novo PLA2R positive membranous nephropathy following BNT162b2 mRNA COVID-19 vaccine

Intern Med J. 2022 Dec;52(12):2191-2192. doi: 10.1111/imj.15915. Epub 2022 Oct 20.

Authors

Lisa Paxton¹, Lawrence McMahon^{1

2}, Limy Wong^{1

2}

Affiliations

¹ Department of Renal Medicine, Eastern Health, Melbourne, Victoria, Australia.
² Department of Renal Medicine, Monash University Eastern Health Clinical School, Melbourne, Victoria, Australia.

No abstract available

Publication types

Letter

MeSH terms

Autoantibodies
BNT162 Vaccine
COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Glomerulonephritis, Membranous*
Humans
RNA, Messenger
Receptors, Phospholipase A2

Substances

BNT162 Vaccine
RNA, Messenger
COVID-19 Vaccines
Autoantibodies
Receptors, Phospholipase A2